CARL Carlsmed, Inc. - Common Stock
$11,32
Prix · Mai 20, 2026
Données fondamentales au Mai 5, 2026
Fourchette 52 semaines
$8–$17
32% of range
Note des analystes
BUY
11 analysts
Objectif de cours
$18
+63% upside
P/E (TTM)
-5.8
ROE
-375.2%
Marge nette
-58.7%
CARL Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$11.31
Capitalisation Boursière
$329M
P/E (TTM)
-5.8
BPA (TTM)
$-2.12
Revenus (TTM)
$51M
Rendement div.
—
ROE
-375.2%
Dette/Capitaux propres
—
Fourchette 52 semaines
$9 – $17
CARL Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$51M
2024-12-31
→
2025-12-31
BPA
$-2.12
2024-12-31
→
2025-12-31
Flux de trésorerie libre
$-30M
2025-12-31
→
2025-12-31
Marges
-58.7%
2025-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CARL
Médiane des pairs
P/E (TTM)
-5.8
42.1
P/S (TTM)
6.5
5.2
P/B
3.3
5.2
Price / FCF (Cours / FCF)
-11.1
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CARL
Médiane des pairs
Gross Margin (Marge Brute)
75.3%
62.3%
Operating Margin (Marge d'exploitation)
-60.5%
—
Net Profit Margin (Marge nette)
-58.7%
-46.8%
ROA
-32.6%
-21.0%
ROE
-375.2%
-37.5%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CARL
Médiane des pairs
Current Ratio (Ratio de liquidité)
8.9
4.8
Quick Ratio (Ratio de liquidité réduite)
8.5
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CARL
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
85.9%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CARL
Médiane des pairs
CARL Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
11 analystes
- Achat fort 4 36,4%
- Achat 6 54,5%
- Conserver 1 9,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-05-18
Médiane
$18.00
← En dessous de tous les objectifs
$11.31
Bas
$16.00
Haut
$23.00
Objectif médian
$18.00
+59,1%
Objectif moyen
$18.40
+62,6%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.09%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.32 | $-0.40 | 0.08% |
| 31 décembre 2025 | $-0.32 | $-0.43 | 0.11% |
| 30 septembre 2025 | $-0.40 | $-0.46 | 0.06% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| OBIO | $237M | -3.7 | 1169.2% | -157.4% | -195.7% | — |
| LUCD | $143M | -1.1 | 8.3% | -1232.7% | -617.2% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue | $51M | $27M | |
| Cost of Revenue | $12M | $7M | |
| Gross Profit | $38M | $20M | |
| R&D Expense | $17M | $14M | |
| SG&A Expense | $17M | $8M | |
| Operating Expenses | $69M | $44M | |
| Operating Income | $-31M | $-24M | |
| Interest Expense | $1M | $1M | |
| Interest Income | $3M | $1M | |
| Other Non-op | $940.0K | $-135.0K | |
| Income Tax | $0 | $0 | |
| Net Income | $-30M | $-24M | |
| EPS (Basic) | $-2.12 | $-6.11 | |
| EPS (Diluted) | $-2.12 | $-6.11 | |
| Shares (Basic) | 14,221,991 | 4,066,395 | |
| Shares (Diluted) | 14,221,991 | 4,066,395 | |
| EBITDA | $-30M | · |
Bilan 24
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $86M | $40M | |
| Short-term Investments | $24M | $0 | |
| Receivables | $11M | $7M | |
| Inventory | $2M | $995.0K | |
| Prepaid Expense | $4M | $1M | |
| Current Assets | $127M | $49M | |
| PP&E (Net) | $1M | $260.0K | |
| PP&E (Gross) | $2M | $659.0K | |
| Accum. Depreciation | $526.0K | $399.0K | |
| Other Non-current Assets | $134.0K | $569.0K | |
| Total Assets | $130M | $52M | |
| Accounts Payable | $4M | $2M | |
| Accrued Liabilities | $3M | $3M | |
| Current Liabilities | $14M | $9M | |
| Capital Leases | $1M | $1M | |
| Other Non-current Liabilities | $309.0K | $222.0K | |
| Total Liabilities | $31M | $26M | |
| Long-term Debt | $15M | $15M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $200M | $541.0K | |
| Retained Earnings | $-101M | $-71M | |
| Stockholders' Equity | $99M | $-71M | |
| Liabilities + Equity | $130M | $52M | |
| Shares Outstanding | 26,604,505 | 4,139,219 |
Flux de trésorerie 8
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| D&A | $281.0K | $145.0K | |
| Stock-based Comp | $2M | $253.0K | |
| Other Non-cash | $-2M | · | |
| Operating Cash Flow | $-29M | $-25M | |
| CapEx | $642.0K | $180.0K | |
| Investing Cash Flow | $-25M | $-180.0K | |
| Financing Cash Flow | $100M | $58M | |
| Free Cash Flow | $-30M | · |
Rentabilité 6
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 75.3% | · | |
| Operating Margin | -60.5% | · | |
| Net Margin | -58.7% | · | |
| EBITDA Margin | -60.0% | · | |
| ROA | -32.6% | · | |
| ROE | -375.2% | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 8.9 | · | |
| Quick Ratio | 8.5 | · | |
| Interest Coverage | -21.4 | · |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.6 | · | |
| Inventory Turnover | 8.8 | · | |
| Receivables Turnover | 5.6 | · |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 85.9% | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $51M | · | |
| Net Income TTM | $-30M | · | |
| Market Cap | $329M | · | |
| P/E | -5.8 | · | |
| P/S | 6.5 | · | |
| P/B | 3.3 | · | |
| P / Tangible Book | 3.3 | · | |
| P / Cash Flow | -11.3 | · | |
| P / FCF | -11.1 | · | |
| Earnings Yield | -17.2% | · |
Compte de résultat 17
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $15M | $13M | $12M | $10M | $9M | $7M | |
| Cost of Revenue | $4M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Gross Profit | $12M | $12M | $10M | $9M | $8M | $7M | $5M | |
| R&D Expense | $5M | $5M | $4M | $4M | $3M | $3M | $4M | |
| SG&A Expense | $6M | $5M | $5M | $3M | $3M | $2M | $2M | |
| Operating Expenses | $22M | $21M | $19M | $15M | $13M | $12M | $13M | |
| Operating Income | $-9M | $-9M | $-9M | $-7M | $-6M | $-5M | $-8M | |
| Interest Expense | $311.0K | $330.0K | $380.0K | $363.0K | $357.0K | $378.0K | $402.0K | |
| Interest Income | $891.0K | $1M | $954.0K | $336.0K | $380.0K | $410.0K | $394.0K | |
| Other Non-op | $580.0K | $705.0K | $509.0K | $-264.0K | $-10.0K | $-23.0K | $-36.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-9M | $-9M | $-9M | $-7M | $-6M | $-5M | $-8M | |
| EPS (Basic) | $-0.32 | $0.03 | $-0.40 | $-1.47 | $-1.47 | $-1.14 | $-2.06 | |
| EPS (Diluted) | $-0.32 | $0.03 | $-0.40 | $-1.47 | $-1.47 | $-1.14 | $-2.06 | |
| Shares (Basic) | 26,835,841 | 4,170,368 | 21,081,330 | 4,589,717 | 4,299,492 | 20,185 | 4,088,553 | |
| Shares (Diluted) | 26,835,841 | 4,170,368 | 21,081,330 | 4,589,717 | 4,299,492 | 20,185 | 4,088,553 | |
| EBITDA | $-9M | · | $-9M | $-7M | · | · | · |
Bilan 24
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $73M | $86M | $115M | $33M | · | $40M | · | |
| Short-term Investments | $24M | $24M | · | · | · | $0 | · | |
| Receivables | $12M | $11M | $11M | $10M | · | $7M | · | |
| Inventory | $2M | $2M | $1M | $1M | · | $995.0K | · | |
| Prepaid Expense | $4M | $4M | $3M | $2M | · | $1M | · | |
| Current Assets | $115M | $127M | $131M | $46M | · | $49M | · | |
| PP&E (Net) | $2M | $1M | $1M | $972.0K | · | $260.0K | · | |
| PP&E (Gross) | $2M | $2M | $2M | $1M | · | $659.0K | · | |
| Accum. Depreciation | $624.0K | $526.0K | $428.0K | $380.0K | · | $399.0K | · | |
| Other Non-current Assets | $103.0K | $134.0K | $225.0K | $4M | · | $569.0K | · | |
| Total Assets | $119M | $130M | $135M | $53M | · | $52M | · | |
| Accounts Payable | $3M | $4M | $3M | $3M | · | $2M | · | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | · | $3M | · | |
| Current Liabilities | $10M | $14M | $11M | $9M | · | $9M | · | |
| Capital Leases | $1M | $1M | $2M | $2M | · | $1M | · | |
| Other Non-current Liabilities | $327.0K | $309.0K | $290.0K | $267.0K | · | $222.0K | · | |
| Total Liabilities | $27M | $31M | $28M | $28M | · | $26M | · | |
| Long-term Debt | $15M | $15M | $15M | $15M | · | $15M | · | |
| Common Stock | $0 | $0 | $0 | $0 | · | $0 | · | |
| Paid-in Capital | $202M | $200M | $199M | $593.0K | · | $541.0K | · | |
| Retained Earnings | $-110M | $-101M | $-92M | $-84M | · | $-71M | · | |
| Stockholders' Equity | $92M | $99M | $107M | $-83M | · | $-71M | · | |
| Liabilities + Equity | $119M | $130M | $135M | $53M | · | $52M | · | |
| Shares Outstanding | 27,181,501 | 26,604,505 | 26,584,077 | 4,603,756 | · | 4,139,219 | · |
Flux de trésorerie 8
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $99.0K | $98.0K | $82.0K | $61.0K | $40.0K | $37.0K | $33.0K | |
| Stock-based Comp | $2M | $790.0K | $704.0K | $258.0K | $175.0K | $100.0K | $66.0K | |
| Other Non-cash | $-6M | · | · | · | · | · | · | |
| Operating Cash Flow | $-13M | $-5M | $-8M | $-7M | $-8M | $-4M | $-8M | |
| CapEx | $79.0K | $73.0K | $159.0K | $327.0K | $83.0K | $61.0K | $52.0K | |
| Investing Cash Flow | $-206.0K | $-24M | $-343.0K | $-672.0K | $-238.0K | $-61.0K | $-52.0K | |
| Financing Cash Flow | $436.0K | $-29.0K | $91M | $-2M | $12M | $-51.0K | $14M | |
| Free Cash Flow | $-13M | · | · | · | · | · | · |
Rentabilité 6
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.1% | · | 75.9% | 73.4% | · | · | · | |
| Operating Margin | -57.6% | · | -69.1% | -53.8% | · | · | · | |
| Net Margin | -54.0% | · | -65.2% | -56.0% | · | · | · | |
| EBITDA Margin | -56.9% | · | -69.1% | -53.8% | · | · | · | |
| ROA | -14.6% | · | -12.6% | -25.4% | · | · | · | |
| ROE | -18.9% | · | -16.0% | 16.3% | · | · | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.9 | · | 12.0 | 4.9 | · | · | · | |
| Quick Ratio | 11.2 | · | 11.6 | 4.6 | · | · | · | |
| Interest Coverage | -29.8 | · | -23.8 | -17.9 | · | · | · |
Efficacité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | 0.2 | 0.5 | · | · | · | |
| Inventory Turnover | 3.6 | · | 4.7 | 6.0 | · | · | · | |
| Receivables Turnover | 2.6 | · | 2.3 | 2.5 | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $51M | · | · | · | · | · | · | |
| Net Income TTM | $-30M | · | $-29M | $-27M | · | · | · | |
| Market Cap | $246M | · | $356M | · | · | · | · | |
| P/E | -2.5 | · | · | · | · | · | · | |
| P/S | 4.8 | · | · | · | · | · | · | |
| P/B | 2.7 | · | 3.3 | · | · | · | · | |
| P / Tangible Book | 2.7 | · | 3.3 | · | · | · | · | |
| P / Cash Flow | -18.9 | · | · | · | · | · | · | |
| P / FCF | -18.8 | · | · | · | · | · | · | |
| Earnings Yield | -40.4% | · | · | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Revenu | $51M | $27M |
| Marge Brute % | 75.3% | — |
| Marge d'exploitation % | -60.5% | — |
| Résultat net | $-30M | $-24M |
| BPA dilué | $-2.12 | $-6.11 |
Bilan
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Ratio de liquidité | 8.9 | — |
| Ratio de liquidité réduite | 8.5 | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Flux de trésorerie libre | $-30M | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.